Meyka AI API is live for developers.Start building.
Advertisement
Cerus Corporation

Cerus Corporation Fundamental Analysis

CERSNASDAQ
HealthcareMedical - Devices
$2.71
$0.08(2.87%)
U.S. Market opens in 54h 48m
Advertisement

Cerus Corporation Fundamental Analysis

Cerus Corporation (CERS) shows moderate financial fundamentals with a PE ratio of -54.79, profit margin of -4.29%, and ROE of -15.36%. The company generates $0.2B in annual revenue with strong year-over-year growth of 14.35%.

Key Strengths

Cash Position15.29%
PEG Ratio-0.87
Current Ratio1.63

Areas of Concern

ROE-15.36%
Operating Margin-7.94%
We analyze CERS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 9.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
9.5/100

We analyze CERS's fundamental strength across five key dimensions:

Efficiency Score

Weak

CERS struggles to generate sufficient returns from assets.

ROA > 10%
-4.28%

Valuation Score

Excellent

CERS trades at attractive valuation levels.

PE < 25
-54.79
PEG Ratio < 2
-0.87

Growth Score

Excellent

CERS delivers strong and consistent growth momentum.

Revenue Growth > 5%
14.35%
EPS Growth > 10%
25.45%

Financial Health Score

Moderate

CERS shows balanced financial health with some risks.

Debt/Equity < 1
1.44
Current Ratio > 1
1.63

Profitability Score

Weak

CERS struggles to sustain strong margins.

ROE > 15%
-1536.18%
Net Margin ≥ 15%
-4.29%
Positive Free Cash Flow
No

Key Financial Metrics

Is CERS Expensive or Cheap?

P/E Ratio

CERS trades at -54.79 times earnings. This suggests potential undervaluation.

-54.79

PEG Ratio

When adjusting for growth, CERS's PEG of -0.87 indicates potential undervaluation.

-0.87

Price to Book

The market values Cerus Corporation at 7.75 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

7.75

EV/EBITDA

Enterprise value stands at -32.53 times EBITDA. This is generally considered low.

-32.53

How Well Does CERS Make Money?

Net Profit Margin

For every $100 in sales, Cerus Corporation keeps $-4.29 as profit after all expenses.

-4.29%

Operating Margin

Core operations generate -7.94 in profit for every $100 in revenue, before interest and taxes.

-7.94%

ROE

Management delivers $-15.36 in profit for every $100 of shareholder equity.

-15.36%

ROA

Cerus Corporation generates $-4.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.28%

Following the Money - Real Cash Generation

Operating Cash Flow

Cerus Corporation generates limited operating cash flow of $2.72M, signaling weaker underlying cash strength.

$2.72M

Free Cash Flow

Cerus Corporation generates weak or negative free cash flow of $-1.26M, restricting financial flexibility.

$-1.26M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

CERS converts -0.22% of its market value into free cash.

-0.22%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-54.79

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.87

vs 25 benchmark

P/B Ratio

Price to book value ratio

7.75

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.42

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.63

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.15

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

-0.15

vs 25 benchmark

How CERS Stacks Against Its Sector Peers

MetricCERS ValueSector AveragePerformance
P/E Ratio-54.7929.20 Better (Cheaper)
ROE-15.36%729.00% Weak
Net Margin-4.29%-52856.00% (disorted) Weak
Debt/Equity1.440.49 Weak (High Leverage)
Current Ratio1.634.43 Neutral
ROA-4.28%-20711.00% (disorted) Weak

CERS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cerus Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

92.90%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

77.54%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

123.37%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ